MBX Biosciences

About MBX Biosciences

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on pioneering Precision Endocrine Peptide™ (PEP™) therapeutic candidates to help people with endocrine and metabolic disorders live fuller and healthier lives. Their mission is to address unmet needs in underserved markets through innovative science and a growing pipeline of therapies.

Products & Services

Precision Endocrine Peptides (PEPs)™:Innovative therapeutic candidates designed to address unmet needs in endocrine and metabolic disorders with superior pharmaceutical properties.

Canvuparatide:A development program within MBX's pipeline targeting endocrine and metabolic disorders.

Specialties

Precision Endocrine Peptides (PEPs)™ Endocrine and Metabolic Disorders Clinical-Stage Therapeutics Innovative Drug Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 199900000 MR: - FA: 199.9 million FAN: 199900000	D: 2025-09-24 FD: 2025-09-24	6 investors
2	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 187700000 MR: - FA: $187.7 million FAN: 187700000	D: 2024-09-16 FD: 2024-09-16	4 investors
3	RT: Series C T: - FT: Series C	A: 63500000 MR: - FA: 63.5 million FAN: 63500000	D: 2024-08-05 FD: 2024-08-05	9 investors

Public Offering Latest

2025-09-24

$199.9M

6 investors (Pro only)

Initial Public Offering (IPO) 2024-09-16

$187.7M

Series C 2024-08-05

$63.5M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kent Hawryluk

President & CEO

S

Sam Azoulay

Chief Medical Officer

R

Richard Bartram

Chief Financial Officer

M

Michelle Graham

Chief Human Resources Officer

C

Chatan Charan

Sr. Vice President, Pharmaceutical Development and CMC

M

Michael A. Dorato

Sr. Vice President, Discovery & Non-Clinical Development

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

MBX Biosciences Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised